Tricida, Inc. Insider Trading for February 2020
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Tricida, Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in Tricida, Inc. for February 2020.
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Feb 26 2020 | TCDA | Tricida, Inc. | Pietzke Steffen | VP Fin & Chief Acct ... | Option Exercise | A | 35.12 | 60,000 | 2,107,200 | 60,000 | |
Feb 26 2020 | TCDA | Tricida, Inc. | Parker Geoffrey M. | Chief Fin. Officer ... | Option Exercise | A | 35.12 | 130,000 | 4,565,600 | 130,000 | |
Feb 26 2020 | TCDA | Tricida, Inc. | Cantrell Susannah | Sr. VP, Chief Comm. ... | Option Exercise | A | 35.12 | 100,000 | 3,512,000 | 100,000 | |
Feb 26 2020 | TCDA | Tricida, Inc. | Otto Dawn Parsell | Sr VP, Clinical Dev ... | Option Exercise | A | 35.12 | 130,000 | 4,565,600 | 130,000 | |
Feb 26 2020 | TCDA | Tricida, Inc. | Stahl Wilhelm | Chief Tech Officer ... | Option Exercise | A | 35.12 | 40,000 | 1,404,800 | 40,000 | |
Feb 26 2020 | TCDA | Tricida, Inc. | KLAERNER GERRIT | President and CEO | Option Exercise | A | 35.12 | 292,000 | 10,255,040 | 292,000 | |
Feb 20 2020 | TCDA | Tricida, Inc. | KLAERNER GERRIT | President and CEO | Sell | S | 36.10 | 4,000 | 144,400 | 45,323 | 49.3 K to 45.3 K (-8.11 %) |
Feb 06 2020 | TCDA | Tricida, Inc. | Stahl Wilhelm | Chief Tech Officer ... | Option Exercise | M | 1.68 | 500 | 840 | 199,942 | |
Feb 06 2020 | TCDA | Tricida, Inc. | Stahl Wilhelm | Chief Tech Officer ... | Sell | S | 38.91 | 500 | 19,455 | 14,806 | 15.3 K to 14.8 K (-3.27 %) |
Feb 06 2020 | TCDA | Tricida, Inc. | Stahl Wilhelm | Chief Tech Officer ... | Buy | M | 1.68 | 500 | 840 | 15,306 | 14.8 K to 15.3 K (+3.38 %) |
Feb 05 2020 | TCDA | Tricida, Inc. | Otto Dawn Parsell | Sr VP, Clinical Dev ... | Option Exercise | M | 7.49 | 523 | 3,917 | 24,602 | |
Feb 05 2020 | TCDA | Tricida, Inc. | Otto Dawn Parsell | Sr VP, Clinical Dev ... | Option Exercise | M | 2.39 | 523 | 1,250 | 18,321 | |
Feb 05 2020 | TCDA | Tricida, Inc. | Otto Dawn Parsell | Sr VP, Clinical Dev ... | Option Exercise | M | 1.68 | 2,994 | 5,030 | 11,806 | |
Feb 05 2020 | TCDA | Tricida, Inc. | Otto Dawn Parsell | Sr VP, Clinical Dev ... | Option Exercise | M | 1.68 | 210 | 353 | 1,050 | |
Feb 05 2020 | TCDA | Tricida, Inc. | Otto Dawn Parsell | Sr VP, Clinical Dev ... | Sell | S | 37.62 | 523 | 19,675 | 255 | 778 to 255 (-67.22 %) |
Feb 05 2020 | TCDA | Tricida, Inc. | Otto Dawn Parsell | Sr VP, Clinical Dev ... | Buy | M | 7.49 | 523 | 3,917 | 778 | 255 to 778 (+205.10 %) |
Feb 05 2020 | TCDA | Tricida, Inc. | Otto Dawn Parsell | Sr VP, Clinical Dev ... | Sell | S | 37.31 | 523 | 19,513 | 255 | 778 to 255 (-67.22 %) |
Feb 05 2020 | TCDA | Tricida, Inc. | Otto Dawn Parsell | Sr VP, Clinical Dev ... | Buy | M | 2.39 | 523 | 1,250 | 778 | 255 to 778 (+205.10 %) |
Feb 05 2020 | TCDA | Tricida, Inc. | Otto Dawn Parsell | Sr VP, Clinical Dev ... | Sell | S | 37.51 | 400 | 15,004 | 255 | 655 to 255 (-61.07 %) |
Feb 05 2020 | TCDA | Tricida, Inc. | Otto Dawn Parsell | Sr VP, Clinical Dev ... | Sell | S | 36.74 | 2,336 | 85,825 | 655 | 3 K to 655 (-78.10 %) |
Feb 05 2020 | TCDA | Tricida, Inc. | Otto Dawn Parsell | Sr VP, Clinical Dev ... | Sell | S | 35.58 | 258 | 9,180 | 2,991 | 3.2 K to 3 K (-7.94 %) |
Feb 05 2020 | TCDA | Tricida, Inc. | Otto Dawn Parsell | Sr VP, Clinical Dev ... | Buy | M | 1.68 | 2,994 | 5,030 | 3,249 | 255 to 3.2 K (+1,174.12 %) |
Feb 05 2020 | TCDA | Tricida, Inc. | Otto Dawn Parsell | Sr VP, Clinical Dev ... | Sell | S | 35.58 | 210 | 7,472 | 255 | 465 to 255 (-45.16 %) |
Feb 05 2020 | TCDA | Tricida, Inc. | Otto Dawn Parsell | Sr VP, Clinical Dev ... | Buy | M | 1.68 | 210 | 353 | 465 | 255 to 465 (+82.35 %) |
Feb 05 2020 | TCDA | Tricida, Inc. | HEJLEK EDWARD J | SVP, General Counse ... | Option Exercise | M | 0.96 | 10,000 | 9,600 | 114,143 | |
Feb 05 2020 | TCDA | Tricida, Inc. | HEJLEK EDWARD J | SVP, General Counse ... | Sell | S | 36.63 | 7,869 | 288,241 | 19,153 | 27 K to 19.2 K (-29.12 %) |
Feb 05 2020 | TCDA | Tricida, Inc. | HEJLEK EDWARD J | SVP, General Counse ... | Buy | M | 0.96 | 7,869 | 7,554 | 27,022 | 19.2 K to 27 K (+41.08 %) |
Feb 05 2020 | TCDA | Tricida, Inc. | HEJLEK EDWARD J | SVP, General Counse ... | Sell | S | 35.63 | 2,131 | 75,928 | 19,153 | 21.3 K to 19.2 K (-10.01 %) |
Feb 05 2020 | TCDA | Tricida, Inc. | HEJLEK EDWARD J | SVP, General Counse ... | Buy | M | 0.96 | 2,131 | 2,046 | 21,284 | 19.2 K to 21.3 K (+11.13 %) |
Feb 05 2020 | TCDA | Tricida, Inc. | KLAERNER GERRIT | President and CEO | Sell | S | 36.58 | 2,900 | 106,082 | 567,321 | 570.2 K to 567.3 K (-0.51 %) |
Feb 05 2020 | TCDA | Tricida, Inc. | KLAERNER GERRIT | President and CEO | Sell | S | 35.68 | 1,100 | 39,248 | 570,221 | 571.3 K to 570.2 K (-0.19 %) |